NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Kiyomitsu Katsumata
Astellas Pharma Inc - Tokyo / Japan
Others
AD Scientific Index ID: 4405763
アステラス製薬株式会社
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Kiyomitsu Katsumata's MOST POPULAR ARTICLES
1-)
Targeted antibody and cytokine cancer immunotherapies through collagen affinityJ Ishihara, A Ishihara, K Sasaki, SSY Lee, JM Williford, M Yasui, H Abe, ...Science translational medicine 11 (487), eaau3259, 20191612019
2-)
ASP2151, a novel helicase–primase inhibitor, possesses antiviral activity against varicella–zoster virus and herpes simplex virus types 1 and 2K Chono, K Katsumata, T Kontani, M Kobayashi, K Sudo, T Yokota, ...Journal of antimicrobial chemotherapy 65 (8), 1733-1741, 20101582010
3-)
Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodiesK Katsumata, J Ishihara, A Mansurov, A Ishihara, MM Raczy, E Yuba, ...Science advances 5 (11), eaay1971, 2019362019
4-)
Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virusK Chono, K Katsumata, H Suzuki, K ShirakiAntiviral research 97 (2), 154-160, 2013412013
5-)
Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpesK Katsumata, K Chono, K Sudo, Y Shimizu, T Kontani, H SuzukiMolecules 16 (9), 7210-7223, 2011412011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept